Search results
Mar 25, 2024 · Non-Proprietary Name. The non-proprietary name of a drug is the name accepted by a competent scientific body or authority, such as the USAN or BAN. The non-proprietary names of newer drugs are kept uniform by an agreement to use the Recommended International Nonproprietary Name (rINN) in all member countries of the World Health Organization (WHO).
"Brand name drug" means the proprietary, specialty, or trade name used by a drug manufacturer for a generic drug and placed upon the drug, its container, label, or wrapping at the time of packaging.
People also ask
What is a generic name?
What is a non-proprietary name for a drug?
What is a non-proprietary name?
Can a drug have more than one non-proprietary name?
A drug's official, non-propriety name is its ______ name. generic. The generic name of a drug is _______, meaning that it does not belong to any 1 manufacturer. nonproprietary. The FDA requires that manufacturers perform clinical tests on new ______ before human use. drugs.
An international nonproprietary name (INN) is an official generic and nonproprietary name given to a pharmaceutical drug or an active ingredient. INNs are intended to make communication more precise by providing a unique standard name for each active ingredient, to avoid prescribing errors.
Jan 18, 2017 · On January 12, 2017, the U.S. Food and Drug Administration (“FDA”) released a final Guidance for Industry, Nonproprietary Naming of Biological Products, as part of the Agency’s ongoing efforts to implement the Biologics Price Competition and Innovation Act (BPCIA) of 2009.
Drug nomenclature is the systematic naming of drugs, especially pharmaceutical drugs. In the majority of circumstances, drugs have 3 types of names: chemical names, the most important of which is the IUPAC name; generic or nonproprietary names, the most important of which are international nonproprietary names (INNs); and trade names, which are ...
Feb 21, 2023 · The USAN Council, the WHO’s International Nonproprietary Names (INN) expert group, and a medication’s manufacturer must agree on a generic name. The generic name selection process typically occurs in early phases of clinical trials. A generic name has a few defining elements, such as a common stem.
